Quick Answer
BioCorRx Inc. reported Total Revenue of $797.2 thousand for fiscal year 2025.
BioCorRx Inc. Total Revenue — Annual History
| Fiscal Year | Total Revenue | YoY Change |
|---|---|---|
| 2025 | $797.2K | +10301.1% |
| 2024 | $7.7K | -91.4% |
| 2023 | $89.2K | -58.3% |
| 2022 | $213.8K | +343.0% |
| 2021 | $48.3K | -60.6% |
| 2020 | $122.6K | -49.0% |
| 2019 | $240.3K | -36.2% |
| 2018 | $376.7K | -42.7% |
| 2017 | $657.3K | -6.3% |
| 2016 | $701.8K | -24.1% |
| 2015 | $924.7K | -21.0% |
| 2014 | $1.17M | +63.8% |
| 2013 | $715.0K | -17.6% |
| 2012 | $868.2K | +12.5% |
| 2011 | $771.8K | +434.5% |
| 2010 | $144.4K | — |
Quarterly Total Revenue
| Quarter Ending | Total Revenue | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $635.2K | — | +256.4% |
| June 30, 2025 | $178.2K | +4306.4% | +32.1% |
| March 31, 2025 | $134.9K | +3626.5% | — |
| September 30, 2024 | $0.00 | -100.0% | -100.0% |
| June 30, 2024 | $4.0K | -79.4% | +11.7% |
| March 31, 2024 | $3.6K | -91.0% | -64.3% |
| September 30, 2023 | $10.1K | -89.3% | -48.3% |
| June 30, 2023 | $19.6K | +22.7% | -51.4% |
- BioCorRx Inc. showed an increase of +10301.1% in Total Revenue compared to the prior fiscal year.
- Over the 2010–2025 period, BioCorRx Inc.’s total revenue has grown by 452.1% (from $144.4 thousand to $797.2 thousand).
- The most recent figure is from BioCorRx Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 31, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: